Literature DB >> 22724902

The diagnostic journey of ovarian cancer: a review of the literature and suggestions for practice.

Victoria Jayde1, Maureen Boughton.   

Abstract

Ovarian cancer is the most lethal form of gynaecological cancer. It can be difficult to diagnose, with the majority of diagnoses made at a late stage of disease. An integrative literature review was conducted to explore the ovarian cancer diagnostic journey of women and to examine the potential contribution of using a person-centred approach. Factors associated with ovarian cancer diagnostic delay were described in terms of two phases. The principles of person-centred health care (PCHC) were identified. This paper proposes utilising the principles of PCHC to improve women's experience of the diagnostic journey. Specific strategies are suggested for each delay phase to enhance the experience for women. Whilst the challenges in diagnosing the disease are likely to remain until a screening test is available, it is hoped that by implementing strategies based upon PCHC, nurses may facilitate the ovarian cancer diagnostic process and improve the diagnostic experience for women.

Entities:  

Mesh:

Year:  2012        PMID: 22724902     DOI: 10.5172/conu.2012.41.1.5

Source DB:  PubMed          Journal:  Contemp Nurse        ISSN: 1037-6178            Impact factor:   1.787


  3 in total

1.  SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway.

Authors:  Wenjing Zhu; Jumin Niu; Miao He; Liwen Zhang; Xuemei Lv; Fangxiao Liu; Longyang Jiang; Jing Zhang; Zhaojin Yu; Lin Zhao; Jia Bi; Yuanyuan Yan; Qian Wei; Hong Huo; Yue Fan; Yuzong Chen; Jian Ding; Minjie Wei
Journal:  J Transl Med       Date:  2019-08-08       Impact factor: 5.531

2.  Cancer Loyalty Card Study (CLOCS): protocol for an observational case-control study focusing on the patient interval in ovarian cancer diagnosis.

Authors:  Hannah R Brewer; Yasemin Hirst; Sudha Sundar; Marc Chadeau-Hyam; James M Flanagan
Journal:  BMJ Open       Date:  2020-09-08       Impact factor: 2.692

3.  The methylation modification of m6A regulators contributes to the prognosis of ovarian cancer.

Authors:  Wenjing Zhu; Long Zhao; Beihua Kong; Ying Liu; Xin Zou; Tongqin Han; Yongmei Shi
Journal:  Ann Transl Med       Date:  2022-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.